ATE12583T1 - Impfstoff auf der basis einer fraktion des herpes simplex typ i-virus und verfahren zu dessen herstellung. - Google Patents

Impfstoff auf der basis einer fraktion des herpes simplex typ i-virus und verfahren zu dessen herstellung.

Info

Publication number
ATE12583T1
ATE12583T1 AT81401407T AT81401407T ATE12583T1 AT E12583 T1 ATE12583 T1 AT E12583T1 AT 81401407 T AT81401407 T AT 81401407T AT 81401407 T AT81401407 T AT 81401407T AT E12583 T1 ATE12583 T1 AT E12583T1
Authority
AT
Austria
Prior art keywords
virus
herpes simplex
fraction
production
simplex type
Prior art date
Application number
AT81401407T
Other languages
English (en)
Inventor
Alexander U Bertland
George P Lampson
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE12583T1 publication Critical patent/ATE12583T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT81401407T 1980-09-11 1981-09-10 Impfstoff auf der basis einer fraktion des herpes simplex typ i-virus und verfahren zu dessen herstellung. ATE12583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/186,365 US4317811A (en) 1980-09-11 1980-09-11 Herpes simplex type 1 subunit vaccine
EP19810401407 EP0048201B1 (de) 1980-09-11 1981-09-10 Impfstoff auf der Basis einer Fraktion des Herpes Simplex Typ I-Virus und Verfahren zu dessen Herstellung

Publications (1)

Publication Number Publication Date
ATE12583T1 true ATE12583T1 (de) 1985-04-15

Family

ID=22684654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81401407T ATE12583T1 (de) 1980-09-11 1981-09-10 Impfstoff auf der basis einer fraktion des herpes simplex typ i-virus und verfahren zu dessen herstellung.

Country Status (10)

Country Link
US (1) US4317811A (de)
EP (1) EP0048201B1 (de)
JP (1) JPS5780326A (de)
AT (1) ATE12583T1 (de)
CA (1) CA1174599A (de)
DE (1) DE3169848D1 (de)
DK (1) DK401981A (de)
FI (1) FI73596C (de)
IE (1) IE51553B1 (de)
NO (1) NO813087L (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388035A (en) * 1979-08-01 1983-06-14 Bud Antle, Inc. Dibble tube soil plug planter
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
DE3378611D1 (en) * 1982-03-24 1989-01-12 Univ Birmingham Vaccine against dna viruses
CA1201987A (en) * 1982-03-24 1986-03-18 Gordon R.B. Skinner Vaccine against dna viruses
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US4618578A (en) * 1984-07-17 1986-10-21 Chiron Corporation Expression of glycoprotein D of herpes simplex virus
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
US4761470A (en) * 1985-12-16 1988-08-02 Merck & Co., Inc. Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody
US5955088A (en) * 1992-02-03 1999-09-21 Cedars-Sinai Medical Center Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP1027426A4 (de) * 1997-10-31 2006-04-19 Merck & Co Inc Methode für verbessertes mischen einer varicella-infizierten zellkultur in rollflaschen
US20030045467A1 (en) * 2001-01-05 2003-03-06 Tihamer Orban Autoantigen composition
RU2225223C1 (ru) * 2002-06-14 2004-03-10 Закрытое акционерное общество Фирма "ВИТАФАРМА" Лиофилизированная антигерпетическая вакцина
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
RU2552341C1 (ru) * 2014-02-26 2015-06-10 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства (ФГУП СПбНИИВС ФМБА России) Фармацевтическая композиция для получения антигерпетической поливакцины и лекарственной формы на ее основе

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1316588A (en) 1970-08-15 1973-05-09 Beecham Group Ltd Recovery of virus particles
DE2215728C3 (de) 1972-03-30 1979-02-15 Stickl, Helmut, Prof. Dr.Med., 8033 Krailling Arzneimittel zur Behandlung von Herpes simplex
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine

Also Published As

Publication number Publication date
EP0048201A2 (de) 1982-03-24
DE3169848D1 (en) 1985-05-15
US4317811A (en) 1982-03-02
CA1174599A (en) 1984-09-18
EP0048201A3 (en) 1982-09-15
EP0048201B1 (de) 1985-04-10
FI73596C (fi) 1987-11-09
IE812096L (en) 1982-03-11
NO813087L (no) 1982-03-12
IE51553B1 (en) 1987-01-07
FI812704L (fi) 1982-03-12
JPS5780326A (en) 1982-05-19
DK401981A (da) 1982-03-12
FI73596B (fi) 1987-07-31

Similar Documents

Publication Publication Date Title
ATE12583T1 (de) Impfstoff auf der basis einer fraktion des herpes simplex typ i-virus und verfahren zu dessen herstellung.
NO943038D0 (no) Fremgangsmåte til fremstilling av virusresistente planter via innföring av utranslaterbar plussense RNA
FI931384A0 (fi) Vattenloesliga kamptothecinanaloger, processer och foerfaranden
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
ES8708250A1 (es) Un procedimiento para producir glucagon o fragmentos o derivados del mismo en levadura
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
IT1110864B (it) Procedimento per la preparazione di un vaccino subunitario di tipo 2 per herpes simplex
IT7822442A0 (it) Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi.
ATE375T1 (de) Grippevirusimpfstoff und verfahren zu seiner herstellung.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ATE8409T1 (de) Verfahren zum vermehren menschlicher hepatitis-a viren in einer zellkultur in vitro.
GB1486186A (en) Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
JPS5394084A (en) Novel vaccine
JPS51133414A (en) Production of vaccine against viral hepatisis
ES449941A1 (es) Un metodo de preparacion de un nuevo virus vivo de la rabia.
IT1114284B (it) Procedimento per mantenere attiva la cultura di fermenti
DE3650445D1 (de) Verfahren um 1-sesamin zu produzieren mittels Pflanenzellkulturen.
GB1358321A (en) Method od tissue cell culture
ZA741441B (en) Herpes simplex type 2 virus vaccine and method of production and use
AU6258480A (en) Prep" of influenza virus strains and vaccines
DK119082A (da) Phosphor(phosphon)-syreesteramider,fremgangsmaade til fremstilling heraf samt deres anvendelse som midler til bekaempelse afskadelige organismer
ES385968A1 (es) Metodo para producir una vacuna de virus de enfermedad de newcastle muy atenuado.
DK189584A (da) (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse
DK67886D0 (da) Fremgangsmaade til fremstilling af 4-(2-methoxyethyl)-phenylglycidylether og/eller metoprolol
GB1462545A (en) Feline rhinotracheitis vaccine and production thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee